Paxlovid fails against Long Covid.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Source:
    Science. 6/14/2024, Vol. 384 Issue 6701, p1156-1156. 1/8p.
  • Additional Information
    • Subject Terms:
      POST-acute COVID-19 syndrome; COVID-19 treatment; SARS-CoV-2
    • Abstract:
      The article focuses on the findings from a Stanford University study published in the journal "JAMA Internal Medicine" in June 2024, indicating that the antiviral drug combination Paxlovid is safe but ineffective against Long Covid, prompting calls for further research into alternative treatments.